Brief: Cue Biopharma And Lg Chem Life Sciences Announce Development Milestone In Immuno-Stat Biologics Collaboration For Cue-102
05/01/2022 13:35
Jan 5 (Reuters) - LG Chem Ltd 051910.KS :
* CUE BIOPHARMA AND LG CHEM LIFE SCIENCES ANNOUNCE
DEVELOPMENT
MILESTONE IN IMMUNO-STAT BIOLOGICS COLLABORATION FOR CUE-102
* CUE BIOPHARMA INC - UNDER TERMS OF COLLABORATION
AGREEMENT, CO
WILL RECEIVE A $3 MILLION MILESTONE PAYMENT FROM LG CHEM LIFE
SCIENCES
Source text for Eikon: ID:nGNX5JqjwD
Further company coverage: 051910.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria